Integrated Diagnostics, Inc.

SEATTLE, WA · Founded 2009 · Digital health · Acquired by Biodesix (2018)

Diagnostic AI software platform for medical image analysis

Claim this profile

Follows are private to you and power your alerts

Updated · integrated.ai

Sector
Digital health
Headquarters
SEATTLE, WA
Founded
2009
Latest Form D
$6.1M, Dec 2016
Total capital
$45.3M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$45.3M
4 Form D · last Dec 2016
119 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
4
28 pending · first 2015
Rank in peer group#14 of 197

Capital timeline

20092010201120122013201420152016FEDERAL ↑EQUITY ↓Cumulative $45.3M1st Form D$7.5M2nd Form D$31.7M3rd Form D$6.1M
2009201120132015FEDERAL ↑EQUITY ↓Cumulative $45.3M1st Form D$7.5M2nd Form D$31.7M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$6.1M
  • Private capital raisedForm D · SEC · 2nd filing$31.7M
  • Private capital raisedForm D · SEC · 1st filing$7.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 197 peers

Line = median

Digital health · Software

  • Granted patents#14 · top 7%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Albert LudererExecutive Officer, DirectorNamed in SEC Form D filings
  • Arnold OronskyDirectorNamed in SEC Form D filings
  • David BarkerDirectorNamed in SEC Form D filings
  • Douglas SandersExecutive OfficerNamed in SEC Form D filings
  • Greg CritchfieldDirectorNamed in SEC Form D filings
  • James GarnerExecutive OfficerNamed in SEC Form D filings
Show all 14 people
  • James HeathDirectorNamed in SEC Form D filings
  • Jay MoyesDirectorNamed in SEC Form D filings
  • John BencichExecutive OfficerNamed in SEC Form D filings
  • Kenneth FangExecutive OfficerNamed in SEC Form D filings
  • Leroy HoodDirectorNamed in SEC Form D filings
  • Michael LiangDirectorNamed in SEC Form D filings
  • Paul KearneyExecutive OfficerNamed in SEC Form D filings
  • Stephen DavisExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 4 granted of 32
  • PendingSrm Methods In Alzheimer's Disease And Neurological Disease AssaysUSPTOApplication 16002123
  • PendingSrm Methods In Alzheimer's Disease And Neurological Disease AssaysUSPTOApplication 15638881
  • PendingSrm Methods In Alzheimer's Disease And Neurological Disease AssaysUSPTOApplication 15355213
Show all 32 patent records
  • Srm Methods In Alzheimer's Disease And Neurological Disease AssaysOct 4, 2018 · Application 16002123Pending
  • Srm Methods In Alzheimer's Disease And Neurological Disease AssaysOct 19, 2017 · Application 15638881Pending
  • Srm Methods In Alzheimer's Disease And Neurological Disease AssaysOct 19, 2017 · Application 15355213Pending
  • Compositions, Methods And Kits For Diagnosis Of Lung CancerSep 21, 2017 · Application 15456830Pending
  • Compositions, Methods and Kits for Diagnosis of Lung CancerJun 9, 2016 · Application 15041775Pending
  • Compositions, Methods and Kits for Diagnosis of Lung CancerApr 5, 2016 · US 9,304,137Granted
  • Compositions, Methods And Kits For Diagnosis Of Lung CancerMar 29, 2016 · US 9,297,805Granted
  • Compositions, Methods and Kits for Diagnosis of Lung CancerDec 1, 2015 · US 9,201,044Granted
  • Selected Reaction Monitoring AssaysNov 12, 2015 · Application 14738146Pending
  • Selected Reaction Monitoring AssaysJul 28, 2015 · US 9,091,651Granted
  • Alzheimer's Disease Diagnostic Panels And Methods For Their UseJul 16, 2015 · Application 14672908Pending
  • Srm Methods In Alzheimer's Disease And Neurological Disease AssaysJun 18, 2015 · Application 14390447Pending
  • Compositions, Methods And Kits For Diagnosis Of Lung CancerMar 26, 2015 · Application 14491446Pending
  • Organ-Specific Proteins and Methods of Their UseApr 17, 2014 · Application 14072651Pending
  • Compositions, Methods And Kits For Diagnosis Of Lung CancerApplication 61725153Pending
  • Psa Capture Agents, Compositions, Methods And Preparation ThereofApplication PCTUS2012023873Pending
  • Alzheimer's Disease Diagnostic Panels And Methods For Their UseApplication PCTUS2011062462Pending
  • Diagnostic Lung Cancer Panel And Methods For Its UseApplication PCTUS2011062461Pending
  • Breast Cancer Specific Markers And Methods Of UseApplication PCTUS2009053211Pending
  • Compositions, Methods and Kits for Diagnosis of Lung CancerApplication 62430853Pending
  • Compositions, Methods and Kits for Diagnosis of Lung CancerApplication 62332054Pending
  • Compositions, Methods And Kits For Diagnosis Of Lung CancerApplication 62310258Pending
  • Integrated Quantification Method For Protein Measurements In Clinical ProteomicsApplication PCTUS2015014257Pending
  • Compositions, Methods And Kits For Diagnosis Of Lung CancerApplication PCTUS2014056637Pending
  • Compositions, Methods And Kits For Diagnosis Of Lung CancerApplication PCTUS2014048260Pending
  • Integrated Quantification Method for Protein Measurements in Clinical ProteomicsApplication 61935061Pending
  • Compositions, Methods And Kits For Diagnosis Of Lung CancerApplication PCTUS2013077225Pending
  • Compositions, Methods and Kits for Diagnosis of Lung CancerApplication 61880507Pending
  • Compositions, Methods and Kits for Diagnosis of Lung CancerApplication 61858760Pending
  • Srm Methods In Alzheimer's Disease And Neurological Disease AssaysApplication PCTUS2013031520Pending
  • Selected Reaction Monitoring AssaysApplication PCTUS2012071415Pending
  • Compositions, Methods And Kits For Diagnosis Of Lung CancerApplication PCTUS2012071387Pending

Regulatory activity · Digital health

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .